What is the difference between MORL and MRRL?
Anyone who believes that market efficiency is flawless should scrutinize these two ETNs. Even though MORL and NAV are nearly identical, MORL trades at a premium of 7.62 percent.
In addition to having a premium, it is at its highest level ever. At the time of our last check, MRRL was trading at a nice 0.14% discount to its underlying NAV. We've never seen a case in which the decision between two equivalent exchange-traded items was so heavily skewed. The MORL should be avoided in favour of the MRRL.
In addition to having a premium, it is at its highest level ever. At the time of our last check, MRRL was trading at a nice 0.14% discount to its underlying NAV. We've never seen a case in which the decision between two equivalent exchange-traded items was so heavily skewed. The MORL should be avoided in favour of the MRRL.
MORL (Etracs Monthly Pay 2x Leveraged Mortgage REIT ETN) and MRRL (Etracs Monthly Pay 2x Leveraged Mortgage REIT ETN Series B) were both exchange-traded notes (ETNs) issued by UBS, designed to provide 2x leveraged exposure to an index of mortgage REITs. The key difference lies in their issuance dates and structure. MORL was the original ETN, launched in 2012, while MRRL was introduced later in 2017 as a replacement, offering similar exposure but with slightly different terms, mainly for regulatory reasons. Both aimed to deliver high yields but carried significant risk due to leverage. UBS eventually delisted both products, emphasizing their complex nature and the risks involved in leveraged ETNs.
MORL and MRRL were UBS-issued leveraged ETNs that allowed investors to participate in the performance of mortgage real estate investment trusts. Each product was designed to provide twice the daily return of the MVIS US Mortgage REITs Index. MORL was the original monthly-paying leveraged mortgage REIT ETN, while MRRL was introduced as a comparable alternative. Their differences mainly concerned their issuance arrangements and trading characteristics, as their investment strategies were largely alike. Both products attracted investors looking for amplified market exposure and monthly income distributions. However, these benefits came with considerable risks, including greater losses during declining markets and potential credit exposure to UBS. Another important consideration was that leveraged ETNs could behave differently over longer holding periods because of daily compounding. UBS mandatorily redeemed both MORL and MRRL in March 2020 after their indicative values fell below $5.
Nov 12, 2021 21:04